1. Home
  2. RDY vs ACI Comparison

RDY vs ACI Comparison

Compare RDY & ACI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • ACI
  • Stock Information
  • Founded
  • RDY 1984
  • ACI 1860
  • Country
  • RDY India
  • ACI United States
  • Employees
  • RDY N/A
  • ACI N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • ACI Food Chains
  • Sector
  • RDY Health Care
  • ACI Consumer Staples
  • Exchange
  • RDY Nasdaq
  • ACI Nasdaq
  • Market Cap
  • RDY 13.1B
  • ACI 10.7B
  • IPO Year
  • RDY N/A
  • ACI 2020
  • Fundamental
  • Price
  • RDY $79.49
  • ACI $18.55
  • Analyst Decision
  • RDY Buy
  • ACI Buy
  • Analyst Count
  • RDY 1
  • ACI 9
  • Target Price
  • RDY $87.00
  • ACI $23.94
  • AVG Volume (30 Days)
  • RDY 156.2K
  • ACI 3.1M
  • Earning Date
  • RDY 10-29-2024
  • ACI 10-15-2024
  • Dividend Yield
  • RDY 1.20%
  • ACI 2.59%
  • EPS Growth
  • RDY 17.48
  • ACI N/A
  • EPS
  • RDY 4.00
  • ACI 1.71
  • Revenue
  • RDY $3,460,984,788.00
  • ACI $79,713,700,000.00
  • Revenue This Year
  • RDY $13.21
  • ACI $2.43
  • Revenue Next Year
  • RDY $8.56
  • ACI $1.75
  • P/E Ratio
  • RDY $19.79
  • ACI $10.85
  • Revenue Growth
  • RDY 10.49
  • ACI 1.21
  • 52 Week Low
  • RDY $63.72
  • ACI $17.80
  • 52 Week High
  • RDY $84.46
  • ACI $23.47
  • Technical
  • Relative Strength Index (RSI)
  • RDY 46.19
  • ACI 48.17
  • Support Level
  • RDY $78.40
  • ACI $18.16
  • Resistance Level
  • RDY $80.00
  • ACI $19.10
  • Average True Range (ATR)
  • RDY 0.86
  • ACI 0.30
  • MACD
  • RDY 0.11
  • ACI 0.08
  • Stochastic Oscillator
  • RDY 58.28
  • ACI 42.11

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About ACI Albertsons Companies Inc.

Albertsons is the second largest supermarket operator in the United States with over 2,200 stores across a variety of banners. About 80% of the firm's sales stem from non-perishable and fresh food, of which 25% comes from its portfolio of private brands. The company operates fuel centers and pharmacies at about 20% and 75% of its store locations, respectively. Albertsons went public in 2020 following years of ownership under private equity firm Cerberus Capital Management, which still owns about a fourth of outstanding shares.

Share on Social Networks: